John R M Caplehorn. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Buprenorphine/economicsBuprenorphine/therapeutic useCost-Benefit AnalysisHumansNarcotic Antagonists/economicsNarcotic Antagonists/therapeutic useRandomized Controlled Trials as Topic/economicsReproducibility of ResultsSample Size
Substances: See more » Narcotic AntagonistsBuprenorphine
Year: 2003 PMID: 14609426 DOI: 10.5694/j.1326-5377.2003.tb05417.x
Source DB: PubMed Journal: Med J Aust ISSN: 0025-729X Impact factor: 7.738